New Zealand markets open in 7 minutes

Hangzhou Tigermed Consulting Co., Ltd (3347.HK)

HKSE - HKSE Delayed price. Currency in HKD
Add to watchlist
27.600-1.000 (-3.50%)
At close: 04:08PM HKT
Currency in HKD

Valuation measures4

Market cap (intra-day) 42.15B
Enterprise value 38.06B
Trailing P/E 13.17
Forward P/E 13.59
PEG ratio (5-yr expected) N/A
Price/sales (ttm)3.08
Price/book (mrq)1.05
Enterprise value/revenue 4.89
Enterprise value/EBITDA 14.03

Trading information

Stock price history

Beta (5Y monthly) 0.73
52-week change 3-39.93%
S&P500 52-week change 322.55%
52-week high 352.550
52-week low 322.100
50-day moving average 332.730
200-day moving average 334.453

Share statistics

Avg vol (3-month) 31.68M
Avg vol (10-day) 3909.28k
Shares outstanding 5123.12M
Implied shares outstanding 61.53B
Float 8624.86M
% held by insiders 10.00%
% held by institutions 163.05%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 40.62
Forward annual dividend yield 42.26%
Trailing annual dividend rate 30.57
Trailing annual dividend yield 31.99%
5-year average dividend yield 4N/A
Payout ratio 428.53%
Dividend date 3N/A
Ex-dividend date 407 Jun 2024
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Currency in CNY.

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 23.36%
Operating margin (ttm)20.34%

Management effectiveness

Return on assets (ttm)3.45%
Return on equity (ttm)7.92%

Income statement

Revenue (ttm)7.24B
Revenue per share (ttm)8.35
Quarterly revenue growth (yoy)-8.00%
Gross profit (ttm)N/A
EBITDA 1.8B
Net income avi to common (ttm)1.69B
Diluted EPS (ttm)2.090
Quarterly earnings growth (yoy)-58.60%

Balance sheet

Total cash (mrq)7.45B
Total cash per share (mrq)8.61
Total debt (mrq)3.65B
Total debt/equity (mrq)14.87%
Current ratio (mrq)2.61
Book value per share (mrq)24.43

Cash flow statement

Operating cash flow (ttm)1.27B
Levered free cash flow (ttm)247.26M